Ravi Salgia to PTEN Phosphohydrolase
This is a "connection" page, showing publications Ravi Salgia has written about PTEN Phosphohydrolase.
Connection Strength
0.153
-
MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma. PLoS One. 2014; 9(9):e105919.
Score: 0.117
-
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway. Oncotarget. 2017 Jul 04; 8(27):43733-43751.
Score: 0.036